We demonstrated that 19 of the 52 (36.5%) tumours had reduced expression levels of the Mlh1 protein (Figure 2B), whereas five (9.6%) carcinomas had reduced expression levels of the Msh2 protein (Figure 2D). Here, MSH2 is linked to carcinoma.